Bharathi Gandi

Bharathi is an analyst II, quality control at Verve Therapeutics. Prior to joining Verve, Bharathi worked as a process development associate at the Broad Institute, genomics platform, in COVID-19 diagnostics and genomic sequencing operations. While there, she developed and validated NGS technology for a stealth mode sequencing startup. She has a B.S. degree in nutritional sciences from University of California, Davis and M.S. degrees in public health nutrition and biomedical sciences from Boston University.